These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35007957)

  • 21. Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting.
    O'Gurek DT
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S136-S140. PubMed ID: 33622828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Management of Opioid Use Disorder in Primary Care: an Update.
    Donroe JH; Bhatraju EP; Tsui JI; Edelman EJ
    Curr Psychiatry Rep; 2020 Apr; 22(5):23. PubMed ID: 32285215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intertwined expansion of telehealth and buprenorphine access from a prescriber hub.
    Moore DT; Wischik DL; Lazar CM; Vassallo GG; Rosen MI
    Prev Med; 2021 Nov; 152(Pt 2):106603. PubMed ID: 33974959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common elements in opioid use disorder guidelines for buprenorphine prescribing.
    Atkinson TJ; Pisansky AJB; Miller KL; Yong RJ
    Am J Manag Care; 2019 Mar; 25(3):e88-e97. PubMed ID: 30875177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
    Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
    J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Value of Treating Opioid Use Disorder in Family Medicine: From the Patient Perspective.
    Kane C; Leiner C; Harless C; Foley KA; Fagan EB; Wilson CG
    J Am Board Fam Med; 2020; 33(4):611-615. PubMed ID: 32675272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID-19 pandemic.
    Rosansky JA; Albanese M; Phillips J; Schuman-Olivier Z
    Am J Addict; 2023 Nov; 32(6):615-618. PubMed ID: 37543849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
    Weintraub E; Seneviratne C; Anane J; Coble K; Magidson J; Kattakuzhy S; Greenblatt A; Welsh C; Pappas A; Ross TL; Belcher AM
    JAMA Netw Open; 2021 Aug; 4(8):e2118487. PubMed ID: 34448869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient-Based Opioid Treatment Engagement and Attendance: A Prospective Cohort Study of Homeless-Experienced Adults.
    Fine DR; Hart K; Critchley N; Chang Y; Regan S; Joyce A; Tixier E; Sporn N; Gaeta J; Wright J; Kruse G; Baggett TP
    J Gen Intern Med; 2024 Jul; ():. PubMed ID: 38987479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
    Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
    Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California.
    Herring AA; Kalmin M; Speener M; Goodman-Meza D; Snyder H; Campbell A; Moulin A; Shoptaw S
    J Subst Abuse Treat; 2021 Apr; 123():108260. PubMed ID: 33612194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.
    Krawczyk N; Bunting AM; Frank D; Arshonsky J; Gu Y; Friedman SR; Bragg MA
    Int J Drug Policy; 2021 Jun; 92():103140. PubMed ID: 33558165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of timely opioid agonist treatment initiation among veterans with and without HIV.
    Wyse JJ; Robbins JL; McGinnis KA; Edelman EJ; Gordon AJ; Manhapra A; Fiellin DA; Moore BA; Korthuis PT; Gaither JR; Gordon K; Skanderson M; Barry DT; Crystal S; Justice A; Kraemer KL
    Drug Alcohol Depend; 2019 May; 198():70-75. PubMed ID: 30878769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report.
    Harris M; Johnson S; Mackin S; Saitz R; Walley AY; Taylor JL
    J Addict Med; 2020; 14(4):e136-e138. PubMed ID: 32433364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine.
    Weinstein ZM; Cheng DM; Quinn E; Hui D; Kim H; Gryczynski G; Samet JH
    Drug Alcohol Depend; 2017 Jan; 170():9-16. PubMed ID: 27865152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nurse-Sensitive Indicators in the Care of Individuals With Opioid Use Disorder.
    Bernhardt JM
    J Addict Nurs; 2023 Jan-Mar 01; 34(1):E45-E50. PubMed ID: 34618778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic.
    Simeone C; Shapiro B; Lum PJ
    Addict Sci Clin Pract; 2017 Aug; 12(1):19. PubMed ID: 28826401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.